enGene Therapeutics Inc. - Common Stock (NQ:ENGN)Price and VolumeDetailed Quote
Top NewsMore News
enGene to Participate in Upcoming Investor Conferences
September 01, 2026
Performance
52-Week Range
85.3% below 52-week high
1.800
1.4052W Low
12.2552W High
1 Week
10.9% below 1-week high
1.781W Low
2.021W High
enGene Therapeutics Inc. - Common Stock (ENGN) traded between $1.40 and $12.25 over the past 52 weeks and last traded at $1.80, 85.3% below its 52-week high. Over the past week it ranged between $1.78 and $2.02.
Past 12 Months
1W
-$0.20
1M
-$0.12
3M
-$0.12
6M
-$5.53
YTD
-$7.05
1Y
-$5.80
ENGN was -76.3% over the past year, -75.4% over six months, -79.7% year to date, -10.0% in the last week.
12 Months vs Market
ENGN
DIA
SPY
QQQ
IWM
Over the past 12 months ENGN returned -76.3% versus DIA (Dow) +10.2%, SPY (S&P 500) +16.0%, QQQ (Nasdaq 100) +25.0% and IWM (Russell 2000) +14.0%.
Volume & Liquidity
1W
1M
3M
6M
YTD
1Y
ENGN's 3-month average daily volume is 769.4K. More NewsRead More
Top stock movements in today's session. ↗
May 07, 2026
enGene Announces Name Change to enGene Therapeutics Inc.
April 07, 2026
enGene to Participate in Upcoming Investor Conferences
February 20, 2026
Frequently Asked QuestionsIs enGene Therapeutics Inc. - Common Stock publicly traded?
Yes, enGene Therapeutics Inc. - Common Stock is publicly traded.
What exchange does enGene Therapeutics Inc. - Common Stock trade on?
enGene Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for enGene Therapeutics Inc. - Common Stock?
The ticker symbol for enGene Therapeutics Inc. - Common Stock is ENGN on the Nasdaq Stock Market
What is the current price of enGene Therapeutics Inc. - Common Stock?
The current price of enGene Therapeutics Inc. - Common Stock is 1.800
When was enGene Therapeutics Inc. - Common Stock last traded?
The last trade of enGene Therapeutics Inc. - Common Stock was at 10/06/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|